Mesa Biotech, Inc.

Mesa Biotech, Inc. — FDA 510(k) Submissions

Mesa Biotech, Inc. has submitted 3 FDA 510(k) premarket notifications since 2018, of which 3 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Influenza A And Influenza B Multiplex Nucleic Acid Assay, Respiratory Virus Panel Nucleic Acid Assay System, Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System . Use the specialty filter in the sidebar to narrow results.